|
MRK's Revenue Growth by Quarter and Year
Merck And Co Inc 's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| MRK Revenue (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
| IV Quarter |
December |
-
|
13,830.00
|
12,068.00
|
12,514.00
|
| III Quarter |
September |
-
|
14,959.00
|
13,154.00
|
12,551.00
|
| II Quarter |
June |
15,035.00
|
14,593.00
|
11,402.00
|
10,872.00
|
| I Quarter |
March |
14,487.00
|
15,901.00
|
12,080.00
|
12,057.00
|
| FY |
|
29,522.00
|
59,283.00
|
48,704.00
|
47,994.00
|
| MRK Revenue second quarter 2022 Y/Y Growth Comment |
Merck and Co Inc reported Revenue growth of 3.03% year on year in the second quarter 2022, to $ 15,035.00 millions, this is lower than Merck And Co Inc 's recent average Revenue growth of 6.66%.
Looking into second quarter 2022 results within Major Pharmaceutical Preparations industry 156 other companies have achieved higher Revenue growth. While Merck And Co Inc ' s Revenue increase of 3.03% ranks overall at the positon no. 2665 in the second quarter 2022.
|
| MRK Revenue ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
14.6 % |
-3.56 % |
5.45 % |
| III Quarter |
September |
- |
13.72 % |
4.8 % |
1.24 % |
| II Quarter |
June |
3.03 % |
27.99 % |
4.87 % |
-7.55 % |
| I Quarter |
March |
-8.89 % |
31.63 % |
0.19 % |
11.47 % |
| FY |
|
- |
21.72 % |
1.48 % |
2.46 % |
MRK Revenue (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
-7.55 % |
-8.26 % |
-0.29 % |
| III Quarter |
September |
- |
2.51 % |
15.37 % |
15.44 % |
| II Quarter |
June |
3.78 % |
-8.23 % |
-5.61 % |
-9.83 % |
| I Quarter |
March |
4.75 % |
31.76 % |
-3.47 % |
1.6 % |
| FY (Year on Year) |
|
- |
21.72 % |
1.48 % |
2.46 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 112.1 % |
6.66 % |
-10.57 % |
| (March 31, 2010) |
|
(June 30. 2013) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 112.1 % |
6.66 % |
-10.57 % |
| (March 31, 2010) |
|
(June 30. 2013) |
|
| Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Merck And Co Inc 's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 66.84 % |
1.63 % |
-10.73 % |
| (Dec. 30, 2009) |
|
|
| MRK's II. Quarter Q/Q Revenue Comment |
Merck and Co Inc achieved in the II. Quarter 2022 above company average sequential Revenue growth of 3.78%, to $ 15,035.00 millions, from $14,487.00 millions in the first quarter.
Within Major Pharmaceutical Preparations industry 50 other companies have achieved higher Revenue quarter on quarter growth. While Merck And Co Inc 's Revenue growth quarter on quarter, overall rank is 492. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 66.84 % |
1.63 % |
-10.73 % |
| (Dec. 30, 2009) |
|
|
| MRK's II. Quarter Q/Q Revenue Comment |
Merck and Co Inc achieved in the II. Quarter 2022 above company average sequential Revenue growth of 3.78%, to $ 15,035.00 millions, from $14,487.00 millions in the first quarter.
Within Major Pharmaceutical Preparations industry 50 other companies have achieved higher Revenue quarter on quarter growth. While Merck And Co Inc 's Revenue growth quarter on quarter, overall rank is 492. |
|
Merck And Co Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Jun 30 2023) |
12 Months Ending
(Mar 31 2023) |
12 Months Ending
(Dec 31 2022) |
12 Months Ending
(Sep 30 2022) |
12 Months Ending
(Jun 30 2022) |
| Cumulative Revenue 12 Months Ending |
$ 58,311.00 |
$ 57,869.00 |
$ 59,283.00 |
$ 57,521.00 |
$ 55,716.00 |
| Y / Y Revenue Growth (TTM) |
4.66 % |
10.17 % |
21.72 % |
17.03 % |
14.77 % |
| Year on Year Revenue Growth Overall
Ranking |
# 2019 |
# 0 |
# 2783 |
# 714 |
# 1744 |
| Seqeuential Revenue Change (TTM) |
0.76 % |
-2.39 % |
3.06 % |
3.24 % |
6.08 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 2640 |
# 0 |
# 2971 |
# 1614 |
# 560 |
| Cumulative Revenue growth
Comment |
With the quarterly Revenue reported in the Jun 30 2023 period, Merck And Co Inc 's cumulative twelve months Revenue were $ 58,311 millions, company would post below average annual Revenue growth of 6.08% year on year, if the fiscal year would end at Jun 30 2023.
A slow-down in the Merck And Co Inc 's Revenue growth from the 14487% growth in Mar 31 2023.
In the Healthcare sector 294 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2019. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
88.24 % |
7.45 % |
-7.58 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
88.24 % |
7.45 % |
-7.58 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 126 |
| Sector |
# 369 |
| S&P 500 |
# 2640 |
|
| Cumulative Revenue growth
Comment |
With the quarterly Revenue reported in the Jun 30 2023 period, Merck And Co Inc 's cumulative twelve months Revenue were $ 58,311 millions, company would post below average annual Revenue growth of -7.58% year on year, if the fiscal year would end at Jun 30 2023.
A slow-down in the Merck And Co Inc 's Revenue growth from the 14487% growth in Mar 31 2023.
In the Healthcare sector 294 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 2019. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
88.24 % |
7.45 % |
-7.58 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
88.24 % |
7.45 % |
-7.58 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 126 |
| Sector |
# 369 |
| S&P 500 |
# 2640 |
|
5.30%